Exp Clin Endocrinol Diabetes 2021; 129(09): 651-660
DOI: 10.1055/a-1008-9110
DOI: 10.1055/a-1008-9110
Article
Reduced Compensatory β-Cell Proliferation in Nfatc3-Deficient Mice Fed on High-Fat Diet
Li Hu
1
Department of Metabolism and Endocrinology, The Second Xiangya Hospital, Central South
University, Changsha, Hunan, China
2
National Clinical Research Center for Metabolic Disease, The Second Xiangya Hospital,
Central South University, Changsha, Hunan, China
3
Metabolic Syndrome Research Center, Key Laboratory of Diabetes Immunology, Ministry
of Education, The Second Xiangya Hospital, Central South University, Changsha, Hunan,
China
,
Fengli He
1
Department of Metabolism and Endocrinology, The Second Xiangya Hospital, Central South
University, Changsha, Hunan, China
2
National Clinical Research Center for Metabolic Disease, The Second Xiangya Hospital,
Central South University, Changsha, Hunan, China
3
Metabolic Syndrome Research Center, Key Laboratory of Diabetes Immunology, Ministry
of Education, The Second Xiangya Hospital, Central South University, Changsha, Hunan,
China
,
Yan Luo
1
Department of Metabolism and Endocrinology, The Second Xiangya Hospital, Central South
University, Changsha, Hunan, China
2
National Clinical Research Center for Metabolic Disease, The Second Xiangya Hospital,
Central South University, Changsha, Hunan, China
3
Metabolic Syndrome Research Center, Key Laboratory of Diabetes Immunology, Ministry
of Education, The Second Xiangya Hospital, Central South University, Changsha, Hunan,
China
,
Hairong Luo
1
Department of Metabolism and Endocrinology, The Second Xiangya Hospital, Central South
University, Changsha, Hunan, China
2
National Clinical Research Center for Metabolic Disease, The Second Xiangya Hospital,
Central South University, Changsha, Hunan, China
3
Metabolic Syndrome Research Center, Key Laboratory of Diabetes Immunology, Ministry
of Education, The Second Xiangya Hospital, Central South University, Changsha, Hunan,
China
,
Luo Hai
1
Department of Metabolism and Endocrinology, The Second Xiangya Hospital, Central South
University, Changsha, Hunan, China
2
National Clinical Research Center for Metabolic Disease, The Second Xiangya Hospital,
Central South University, Changsha, Hunan, China
3
Metabolic Syndrome Research Center, Key Laboratory of Diabetes Immunology, Ministry
of Education, The Second Xiangya Hospital, Central South University, Changsha, Hunan,
China
,
Yabin Li
1
Department of Metabolism and Endocrinology, The Second Xiangya Hospital, Central South
University, Changsha, Hunan, China
2
National Clinical Research Center for Metabolic Disease, The Second Xiangya Hospital,
Central South University, Changsha, Hunan, China
3
Metabolic Syndrome Research Center, Key Laboratory of Diabetes Immunology, Ministry
of Education, The Second Xiangya Hospital, Central South University, Changsha, Hunan,
China
,
Zhiguang Zhou
1
Department of Metabolism and Endocrinology, The Second Xiangya Hospital, Central South
University, Changsha, Hunan, China
2
National Clinical Research Center for Metabolic Disease, The Second Xiangya Hospital,
Central South University, Changsha, Hunan, China
3
Metabolic Syndrome Research Center, Key Laboratory of Diabetes Immunology, Ministry
of Education, The Second Xiangya Hospital, Central South University, Changsha, Hunan,
China
,
Feng Liu
1
Department of Metabolism and Endocrinology, The Second Xiangya Hospital, Central South
University, Changsha, Hunan, China
2
National Clinical Research Center for Metabolic Disease, The Second Xiangya Hospital,
Central South University, Changsha, Hunan, China
3
Metabolic Syndrome Research Center, Key Laboratory of Diabetes Immunology, Ministry
of Education, The Second Xiangya Hospital, Central South University, Changsha, Hunan,
China
4
Department of Pharmacology, University of Texas Health Science Center at San Antonio,
San Antonio, Texas, United States of America
,
Yan-Shan Dai
1
Department of Metabolism and Endocrinology, The Second Xiangya Hospital, Central South
University, Changsha, Hunan, China
2
National Clinical Research Center for Metabolic Disease, The Second Xiangya Hospital,
Central South University, Changsha, Hunan, China
3
Metabolic Syndrome Research Center, Key Laboratory of Diabetes Immunology, Ministry
of Education, The Second Xiangya Hospital, Central South University, Changsha, Hunan,
China
5
Bristol-Myers Squibb Company, Princeton, NJ 08540, United States
› Author Affiliations
